Microbiome Transfer Partly Overrides Lack of IL-1RI Signaling to Alter Hepatic but not Adipose Tissue Phenotype and Lipid Handling following a High-Fat Diet Challenge
- PMID: 32558187
- DOI: 10.1002/mnfr.202000202
Microbiome Transfer Partly Overrides Lack of IL-1RI Signaling to Alter Hepatic but not Adipose Tissue Phenotype and Lipid Handling following a High-Fat Diet Challenge
Abstract
Scope: IL-1RI-mediated inflammatory signaling alters metabolic tissue responses to dietary challenges (e.g., high-fat diet [HFD]). Recent work suggests that metabolic phenotype is transferrable between mice in a shared living environment (i.e., co-housing) due to gut microbiome exchange. The authors examine whether the metabolic phenotype of IL-1RI-/- mice fed HFD or low-fat diet (LFD) could be transferred to wild-type (WT) mice through gut microbiome exchange facilitated by co-housing.
Methods and results: Male WT (C57BL/J6) and IL-1RI-/- mice are fed HFD (45% kcal) or LFD (10% kcal) for 24 weeks and housed i) by genotype (single-housed) or ii) with members of the other genotype in a shared microbial environment (co-housed). The IL-1RI-/- gut microbiome is dominant to WT, meaning that co-housed WT mice adopted the IL-1RI-/- microbiota profile. This is concomitant with greater body weight, hepatic lipid accumulation, adipocyte hypertrophy, and hyperinsulinemia in co-housed WT mice, compared to single-housed counterparts. These effects are most evident following HFD. Primary features of microbiome differences are Lachnospiraceae and Ruminococcaceae (known producers of SCFA).
Conclusion: Transfer of SCFA-producing microbiota from IL-1RI-/- mice highlights a new connection between diet, inflammatory signaling, and the gut microbiome, an association that is dependent on the nature of the dietary fat challenge.
Keywords: co-housing; diet-induced obesity; hepatosteatosis; high-fat diet; interleukin 1β.
© 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
References
-
- C. L. Lyons, E. B. Kennedy, H. M. Roche, Nutrients 2016, 8, 247.
-
- J. C. Ralston, C. L. Lyons, E. B. Kennedy, A. M. Kirwan, H. M. Roche, Annu. Rev. Nutr. 2017, 37, 77.
-
- F. C. McGillicuddy, K. A. Harford, C. M. Reynolds, E. Oliver, M. Claessens, K. H. Mills, H. M. Roche, Diabetes 2011, 60, 1688.
-
- F. C. McGillicuddy, C. M. Reynolds, O. Finucane, E. Coleman, K. A. Harford, C. Grant, D. Sergi, L. M. Williams, K. H. G. Mills, H. M. Roche, Am. J. Physiol. Endocrinol. Metab. 2013, 305, E834.
-
- J. Henao-Mejia, E. Elinav, C. Jin, L. Hao, W. Z. Mehal, T. Strowig, C. A. Thaiss, A. L. Kau, S. C. Eisenbarth, M. J. Jurczak, J.-P. Camporez, G. I. Shulman, J. I. Gordon, H. M. Hoffman, R. A. Flavell, Nature 2012, 482, 179.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources